Neonc Technologies Holdings, Inc. (NTHI) Stock Ticker
Market factors today
Unlock the full NTHI picture
About Neonc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
NTHI stock facts
| Ticker symbol | NTHI |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $85.8M |
| CEO | Amir Farrokh Heshmatpour |
| Employees | 5 |
| Headquarters | Calabasas, CA, US |
| IPO date | 2025-03-26 |
| Website | www.neonctech.com |
What you can see for NTHI on Tickr
Live NTHI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the NTHI report.
Rankings
FAQ
What is the ticker symbol for Neonc Technologies Holdings, Inc.?
The ticker symbol for Neonc Technologies Holdings, Inc. is NTHI, listed on the NASDAQ Global Select.
What is NTHI?
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.